STUDresearch · Peptide
Acetyl Tetrapeptide-3
Also known as
Capixyl peptide · acetyl tetrapeptide-3 hair
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Local
Topical
Skin / hair / cosmetic
Local — a scalp/skin serum, not a whole-body shot.
What people say
A cosmetic peptide found in hair/scalp and lash products, including Capixyl with red-clover extract. People discuss density and shedding; finished-blend results do not establish what the peptide does alone.
Doses people talk about
These are reported cosmetic labels, not a pure-peptide or injectable regimen.
How it may feel
Reports include brief scalp tingling, greasiness or fuller-looking hair; others notice no reduction in hair loss. One review reported less shedding after 3 weeks but uncertain new growth after ~4 months.
Product-label use pattern1–2× daily topical
Frequency depends on the finished scalp/skin product. It is not a universal amount of acetyl tetrapeptide-3.
Concentration discussionppm to low single-digit %
Distinguish peptide content from active-complex percentage. A Capixyl blend percentage is not pure peptide concentration and cannot be converted into a subcutaneous dose.
Half-life & effect duration
- Half-life in the body
- Topical peptideNo settled estimate
- Felt duration people report
- Early impressionsTingling or next-day cosmetic changes
- Hair changesMixed reports over weeks to months of continued use
Cycles people discuss
Cosmetic accounts track continued use over weeks to months. The older 10–20-day, few-times-yearly and seasonal on/off language belongs to bioregulator lore—not a proven scalp-serum cycle.
Timing
Morning/night and evening application appear in reports, often around how the serum dries or looks by morning. These are product routines, not half-life-based timing or a training window.
Stacks
Capixyl pairs the peptide with red clover; finished serums add other actives. That blend context is different from inherited organ-bioregulator stack talk.
Watch for
Allergy / unknown impurities: Gray-market risk.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No human parent-peptide half-life established in the checked topical sources.
The manufacturer describes a blend; the 24-week combination trial assesses hair outcomes, not a plasma concentration-time curve.
Review covers the public manufacturer page and accessible trial abstract/Methods text, not a complete global PK search. Do not substitute another similarly named peptide's kinetics.
- Capixyl ingredient identity — Lucas Meyer Cosmetics (opens in a new tab)Edition June 18, 2026; Product Information, INCI and Origin (rendered lines 42–86).Manufacturer marketing/product identity page; full technical documents require an account and were not accessed. Blend claims cannot establish isolated-peptide efficacy or systemic PK.
- Biochanin A, acetyl tetrapeptide-3 and ginseng combination trial (opens in a new tab)Lueangarun and Panchaprateep, J Clin Aesthet Dermatol 2020;13(10):32–37, complete abstract: 24-week topical combination trial, N=32, photographic outcomes.Abstract and indexed Methods text reviewed; publisher full-text request returned 403 and the attempted Europe PMC XML was unavailable. This is a multi-ingredient topical study, not a plasma half-life or isolated-peptide trial.
Felt duration people report
No isolated-peptide duration; immediate cosmetic effects and longer hair-change reports differ.
Accounts describe next-day appearance or early tingling, versus weeks-to-months of continued-use observations. Perceived hair-loss benefit is mixed.
Multiple active ingredients, variable routines and no controlled after-stop follow-up; weeks of use are not one application's duration.
- The Ordinary Multi-Peptide Hair Serum — four-month personal review (opens in a new tab)calypsohadley, January 9, 2022: Usage, Greasiness, Weird shit and Results (rendered lines 30–49); later commenter stopping after scalp sensation at line 314.Multi-active serum with caffeine and several complexes; self-reported, no before/after photographs. Scalp sensation, shedding and perceived growth cannot be assigned to acetyl tetrapeptide-3 alone.
- The Ordinary Multi-Peptide Hair Serum — mixed hair-loss discussion (opens in a new tab)March 3, 2022 thread; opening regimen/ingredients (lines 21–27), peebaby comment (line 55), other replies (lines 62–78).Deleted OP; public cited comments readable. OP also used finasteride/dermarolling. A user described next-day fuller appearance but no perceived hair-loss reduction; that is not peptide-isolated regrowth evidence.
What people say
- cosmetic hair/lash peptide narrative: Community and regional literature frame benefits around cosmetic hair/lash peptide function and “normalization” language. forum
- What is thinner: Large modern multi-center RCTs are often absent for the specific peptide brand story. forum
- Why it trends: Acetyl Tetrapeptide-3 is discussed mainly for skin/hair-related goals in community and secondary sources. forum
- What people claim: Anecdotes range from subtle to dramatic; lifestyle confounds are the rule. anecdote
- Time course: Early days are often side-effect or placebo window; multi-week blocks are the real checkpoint. forum
Doses people talk about
- Do not convert cosmetic % into SC milligrams. forum
- Use pattern: 1–2× daily topical per product label. forum
- Concentration: Older finished-formula discussion spans ppm to low single-digit percentages. A percentage of an active complex such as Capixyl is not the same as that percentage of pure Acetyl Tetrapeptide-3; labels must distinguish peptide content from blend content. This is not an injectable mcg chart. forum
- Framing: Cosmetic hair/scalp peptide in finished serums (e.g. Capixyl-style complexes). forum
How it may feel
- Days 1–7: Older generic notes listed injection-site reactions or oral GI/mood shifts; those are not a validated route or onset profile for this topical cosmetic. A checked multi-active scalp-serum review described next-day tingling after the first applications, then no recurrence; another commenter stopped after a similar sensation. forum
- Courses: The older 10–20-day courses repeated a few times per year come from generic bioregulator culture, not an established Capixyl scalp-serum calendar. Checked topical accounts describe continued use over weeks to months; one reported less shedding by week 3 but uncertain new growth at ~4 months. forum
- Day 1 / appearance: Earlier generic logistics language about route, sting and GI effects is not a typical-response claim for this cosmetic. Serum users instead discuss texture and greasiness; one describes fuller-looking hair the next day without believing hair loss had improved. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
Cycles people discuss
- Course culture versus cosmetics: Short-on, long-off seasonal repetition is inherited bioregulator lore. It is not a demonstrated cycle for this topical ingredient; the checked serum accounts and combination-product trial concern continued use across months. forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Short-peptide lore: Rapid clearance and course-over-plasma timing are assumptions from broader peptide discussion, not measured human kinetics for topical Acetyl Tetrapeptide-3. The checked cosmetic sources do not establish a human parent-peptide half-life. forum
- Timing practicalities: Older general notes mention side effects, training and sleep. In the checked topical-serum discussion, morning/night or evening routines concern application and next-day appearance, not a training window or optimized plasma PK. forum
- Published-PK distinction: Relevant human PK would outrank forum half-life memes, but the reviewed manufacturer page and topical combination-trial abstract report identity or cosmetic outcomes, not parent-peptide plasma elimination. trial
More on what it is
- Evidence honesty: Much of the English-web discussion is secondary summaries and vendor literature; treat claims cautiously. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for Acetyl Tetrapeptide-3, not proof it works for you. forum
- What it is: Acetyl Tetrapeptide-3 is a cosmetic hair/scalp and lash peptide; Capixyl combines it with red-clover extract. Older catalog text placed it in cytomedine/Khavinson-style organ-targeting bioregulator culture. That inherited framing is not the identity of the topical blend or evidence for whole-body organ effects; human evidence for the isolated peptide remains thin compared with marketing. forum
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- Blend versus bioregulator stacks: Older notes describe multi-bioregulator combinations by organ system; that is separate from the cosmetic product here. Capixyl includes red-clover extract, and reviewed finished-serum accounts include other peptide/botanical complexes and caffeine, preventing single-ingredient attribution. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Generally mild claims: Vendor literature often claims good tolerability — independent long-term data limited. forum
- Allergy / unknown impurities: Gray-market risk. forum
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.